The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ITOC 2020 | Novel strategies: enabling T-cell therapy using exercise
Per Thor Straten, PhD, Department of Immunology and Microbiology, University of Copenhagen, Denmark, discusses a novel strategy to enable T-cell therapy using a combination of immunotherapy and exercise. Accumulating data has found exercise to mobilize immune T-cells and NK-cells to the tumor site, which is waiting to be substantiated in a two-arm clinical trial in lung cancer patients. This interview took place during the 7th Immunotherapy of Cancer Conference (ITOC) 2020.
